Looks like you have been doing some pretty good analysis but there are a few things that you are getting wrong while doing these comparisons.
TAW have their price locked for 2 of the 3 years of the starter pit at USD$880. Therefore doing their PFS on these numbers isn't unrealistic. Doing a 20-30 yr DFS at those numbers might be.
The $500 opex figure is in AUD. Use the same currency and you will figure out they have pretty good margins.
Because TAW have done their feasibility study on a small starter pit their opex numbers are more accurate than everyone elses and actually give a realistic representation. GXY are almost a year on from commissioning and they are still producing at a cost of ~ USD$370. That works out to be roughly $500.
Companies using a PFS/DFS over 10+ years get a much better average because the costs in the middle years in particular will be so much lower while early and late years a bit more expensive to dig out.
BGS have the advantage that being at surface their strip ratio will be low and overall their average opex might be a bit closer to what is experienced in reality early on.
I find it highly unlikely a buyout would be for the NPV of a project, that leaves all the execution risk on the buyer. No-one will pay that kind of premium.
- Forums
- ASX - By Stock
- FFX
- Waiting waiting waiting
Waiting waiting waiting, page-35
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FFX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online